Despite a concerted international effort in recent decades that has yielded
significant progress in the fight against HIV/AIDS, the disease continues to kill
large numbers of people, especially in certain regions like rural Ndhiwa district in
Homa Bay County, Kenya. Although there is still no definitive cure or vaccine,
UNAIDS has set an ambitious goal of ending the epidemic by 2030, specifically via
its 90-90-90 (treatmentcascade) strategy – namely that 90 per cent of
, the broad evolution of the HIV pandemic is charted: from
early stigmatisation to multibillion-dollar funding to current ambitions of elimination.
In pushing treatment as a means of prevention, large question marks are nevertheless
highlighted, notably the sustainability and replicability of the project.
Both the DRC Ebola vaccine trial and Ndhiwa ‘treatmentcascade’ strategy
were interrupted by restrictions imposed as a result of COVID-19. Lachlan McIver
et al. contribute an editorial that